Clinical Trial Update: A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) [Phase 3]

View source ↗

Summary

Phase 3 trial update for etavopivat in adults and adolescents with sickle cell disease (HIBISCUS). The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Forma Therapeutics, Inc. | Conditions: Sickle Cell Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING